Benefits of precision medicine in lung cancer: experience from a single institution
Vis Cancer Med, 3 (2022) 4
Published online: 2022-10-21
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
73 (2026)
https://doi.org/10.1016/B978-0-443-33302-6.00012-3
Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model
Hongwei Lan, Jingjuan Zhu, Helei Hou, Chuantao Zhang, Xingfa Huo, Yuming Zhang, Fangfang Yang, Na Zhou and Xiaochun ZhangCell Communication and Signaling 23 (1) (2025)
https://doi.org/10.1186/s12964-025-02146-7
Prognostic Impact of Histologic Grade and GLUT1 Expression in Patients with Lung Adenocarcinoma
Hyunbeom SONG, Seungyeon LEE, Asel YANG and Jaemoon KOHKorean Journal of Clinical Laboratory Science 57 (3) 300 (2025)
https://doi.org/10.15324/kjcls.2025.57.3.300
Prognostic Impact of Recurrence Pattern for Surgically Resected Non-Small Cell Lung Cancer
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima and Hidetaka UramotoOncology 104 (2) 156 (2025)
https://doi.org/10.1159/000545310